Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12618001206213
Ethics application status
Approved
Date submitted
1/03/2018
Date registered
18/07/2018
Date last updated
25/07/2022
Date data sharing statement initially provided
3/03/2020
Date results information initially provided
25/07/2022
Type of registration
Prospectively registered
Titles & IDs
Public title
Introducing Best Practice Oxygen therapy for Infants with Bronchiolitis
Query!
Scientific title
Nasal High Flow Therapy for Infants less than 12 months with Bronchiolitis – Translating new knowledge into practice
Query!
Secondary ID [1]
293469
0
Nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Bronchiolitis
305662
0
Query!
Condition category
Condition code
Respiratory
304884
304884
0
0
Query!
Other respiratory disorders / diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The intervention is a facilitated, structured educational support program dedicated to observing adherence to statewide NHF guidelines for infants admitted to hospital with bronchiolitis over a 3-4 month winter period. Education material such as printed information sheets and power point presentation will be provided to the local Nurse Educator to perform the education as part of their standard education sessions. Three of the six participating hospitals will receive the face-to-face intervention at the start of the study by study nurses to the local Nurse Educator.
Records on hospital education sessions, content and frequency will be obtained. Additionally a questionnaire on current knowledge on bronchiolitis treatment will be distributed to medical and nursing staff. Knowledge will then again be assessed at end of the study.
Education will be delivered face to face and via powerpoint presentation by the Nurse Educator locally. This would be 15-20mins education 1-2 times/nurse over the winter period.
Research Nurses will screen patients during study period every 2 weeks to monitor adherence to educational materials provided. Attendance records, hospital checklists and patient observation charts will be monitored during these site visits.
Query!
Intervention code [1]
299718
0
Treatment: Other
Query!
Comparator / control treatment
The three participating hospitals in the control group will be provided with a copy of the statewide NHF therapy guideline only, They will receive the structured educational support program at the completion of the study.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
304076
0
The Composite Primary outcome will measure the knowledge translation in 4 primary domains.
1. Standard outcome parameters of patients (measured as transfer rate to tertiary hospital) measured by review of hospital medical records
2. Clinicians knowledge of bronchiolitis and their management and care for admitted infants measured by surveys using related key fields including Knowledge, Skills, Professional Role and Memory provided by Huijg, J. et al (Implementation Science 2014), 9:33..
3. Consumer satisfaction as routine care in tertiary and regional hospitals is measured using the EQ-5D Quality of Life tool and the Pediatric Quality of Life tool for infants 1-12months with the parent/guardian as a proxy. Cost effectiveness of NHF therapy as routine care in tertiary and regional hospitals is calculated by length of stay and equipment/consumables used, using hospital medical records
Query!
Assessment method [1]
304076
0
Query!
Timepoint [1]
304076
0
4-6 months post Australian winter period 2019
Query!
Secondary outcome [1]
341851
0
Length of hospital stay as assessed by review of hospital records of admitted infants with bronchiolitis.
Query!
Assessment method [1]
341851
0
Query!
Timepoint [1]
341851
0
4-6 months post Australian winter period 2019
Query!
Secondary outcome [2]
341852
0
Length of oxygen therapy as assessed by review of hospital records of admitted infants with bronchiolitis.
Query!
Assessment method [2]
341852
0
Query!
Timepoint [2]
341852
0
4-6 months post Australian winter period 2019
Query!
Secondary outcome [3]
341853
0
Measure the resource use and costs from hospital medical records, patient out-of-pocket costs, economic benefit such as quality adjusted life years (QALYS), and assess the difference between facilitated and non-facilitated sites.
Query!
Assessment method [3]
341853
0
Query!
Timepoint [3]
341853
0
4-6 months post Australian winter period 2019
Query!
Eligibility
Key inclusion criteria
Inclusion criteria for patients:
Infants less than 12 months old with bronchiolitis who are admitted to hospital and have an oxygen requirement with SpO2<92%
Inclusion criteria for nurses receiving educational support
• Registered or Enrolled nurse
• Current employees of the health care facility
• Nurses permanently on the roster for the participating ward/ED for the duration of the study.
Inclusion criteria for medical staff
• Residents, Registrars, Fellows and Consultants
• Current employees of the Health care facility
• Medical staff who will be on the roster for the participating ward/ED for the duration of the study.
Query!
Minimum age
0
Months
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Exclusion criteria for patients
• Critically ill with immediate need for NIV/Intubation
• Apnoeas requiring NIV/ Intubation
• Blocked nasal passages/choanal atresia
• Upper airway obstruction
• Craniofacial malformations
• Trauma/surgery to nasopharynx
• Pneumothorax
• Cyanotic congenital heart disease
• Decreased level of consciousness
• Oncology patients
• Foreign body aspiration- suspected or confirmed
• Any patient with known lung disease or other conditions that have not been discussed with either the Respiratory Consultant or the treating Paediatrician
Exclusion criteria for nursing and medical staff
• Students
• Agency or casual pool nurses
• Locums (medical)
Query!
Study design
Purpose of the study
Educational / counselling / training
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation of hospital centres participating into intervention or control arm.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Factorial
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Data obtained during the recruitment phase of PARIS 1 trial (ACTRN12613000388718) from 1st May 2015 – 31st October 2015 (winter period) gives an indication of numbers of infants who required oxygen therapy and should be placed on NHF therapy. We estimate a total of 214 patients will be observed for this study.
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/04/2019
Query!
Actual
1/04/2019
Query!
Date of last participant enrolment
Anticipated
20/04/2020
Query!
Actual
30/03/2020
Query!
Date of last data collection
Anticipated
20/07/2020
Query!
Actual
30/03/2021
Query!
Sample size
Target
214
Query!
Accrual to date
Query!
Final
235
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
9456
0
The Prince Charles Hospital - Chermside
Query!
Recruitment hospital [2]
9457
0
Gold Coast University Hospital - Southport
Query!
Recruitment hospital [3]
9458
0
Ipswich Hospital - Ipswich
Query!
Recruitment hospital [4]
9459
0
Sunshine Coast University Hospital - Birtinya
Query!
Recruitment hospital [5]
9460
0
Redcliffe Hospital - Redcliffe
Query!
Recruitment hospital [6]
9461
0
Caboolture Hospital - Caboolture
Query!
Recruitment postcode(s) [1]
18182
0
4032 - Chermside
Query!
Recruitment postcode(s) [2]
18183
0
4215 - Southport
Query!
Recruitment postcode(s) [3]
18184
0
4305 - Ipswich
Query!
Recruitment postcode(s) [4]
18185
0
4575 - Birtinya
Query!
Recruitment postcode(s) [5]
18186
0
4020 - Redcliffe
Query!
Recruitment postcode(s) [6]
18187
0
4510 - Caboolture
Query!
Funding & Sponsors
Funding source category [1]
298093
0
University
Query!
Name [1]
298093
0
AusHSI - Queensland University of Technology
Query!
Address [1]
298093
0
School of Public Health and Social Work,
Institute of Health and Biomedical Innovation,
Queensland University of Technology,
60 Musk Ave,
Kelvin Grove, QLD 4059
Query!
Country [1]
298093
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Lady Cilento Children's Hospital
Query!
Address
501 Stanley St
South Brisbane
QLD 4101
Query!
Country
Australia
Query!
Secondary sponsor category [1]
297170
0
Other Collaborative groups
Query!
Name [1]
297170
0
Paediatric Critical Care Research Group
Query!
Address [1]
297170
0
Paediatric Critical Care Research Group
Level 7, Centre for Children’s Health Research
Lady Cilento Children's Hospital Precinct
62 Graham Street, South Brisbane QLD 4101
Query!
Country [1]
297170
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
299113
0
Children's Health Service Human Research Ethics Committee
Query!
Ethics committee address [1]
299113
0
Children’s Health Queensland Human Research Ethics Committee
Level 7, Centre for Children’s Health Research
Lady Cilento Children's Hospital Precinct
62 Graham Street, South Brisbane QLD 4101
Query!
Ethics committee country [1]
299113
0
Australia
Query!
Date submitted for ethics approval [1]
299113
0
15/01/2018
Query!
Approval date [1]
299113
0
30/01/2018
Query!
Ethics approval number [1]
299113
0
HREC/18/QRCH/3
Query!
Summary
Brief summary
This study aims to determine the benefit, effectiveness, and sustainability of a facilitated and structured educational support program versus no facilitation or educational support program in the uptake and adherence to NHF therapy guidelines for infants less than 12 months old admitted with bronchiolitis. The key stakeholders (nursing and medical workforce) have been familiarised with the use of NHF therapy within the boundaries of the completed NHMRC PARIS I trial, 2013-2016. Our study group has developed a comprehensive education program, which includes visual education, paper and signage resources, face to face teaching and online video postings.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
79334
0
A/Prof Andreas Schibler
Query!
Address
79334
0
Paediatric Critical Care Research Group
Children's Centre for Health Research
62 Graham Street
South Brisbane
QLD 4101
Query!
Country
79334
0
Australia
Query!
Phone
79334
0
+61 414869359
Query!
Fax
79334
0
Query!
Email
79334
0
[email protected]
Query!
Contact person for public queries
Name
79335
0
A/Prof Andreas Schibler
Query!
Address
79335
0
Paediatric Critical Care Research Group
Children's Centre for Health Research
62 Graham Street
South Brisbane
QLD 4101
Query!
Country
79335
0
Australia
Query!
Phone
79335
0
+61 414869359
Query!
Fax
79335
0
Query!
Email
79335
0
[email protected]
Query!
Contact person for scientific queries
Name
79336
0
A/Prof Andreas Schibler
Query!
Address
79336
0
Paediatric Critical Care Research Group
Children's Centre for Health Research
62 Graham Street
South Brisbane
QLD 4101
Query!
Country
79336
0
Australia
Query!
Phone
79336
0
+61 414869359
Query!
Fax
79336
0
Query!
Email
79336
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
The study outcome relates to change in practice and not individual patient data, hence there will be no individual data sharing possible.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF